A Gene Therapy Company Leading Neural Regeneration and Repair
NeuExcell is an early stage gene therapy company focusing on neurodegenerative diseases. We have developed a disruptive neural repair technology that utilizes in vivo astrocyte-to-neuron conversion.
Our vision is to improve the quality of life of millions of patients worldwide who are suffering from neurodegenerative conditions by using the power of gene therapy to restore damaged neural tissue.
Our Highly Experienced Management Team
Executive Board Chair, Acting CEO
Gong Chen, PhD
Founder, Chief Scientific Officer
Xi Qin, MBA
Chief Financial Officer
Ronald HW Lorijn, MD, PhD, MBA
Executive Board Director, VP
Elizabeth White, PhD
Chief Business & Strategy Officer
Head of Discovery